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Abstract: Use of nanoparticles as drug carrier vectors has great potential to circumvent the limitations associated with chemotherapy,
including drug resistance and destructive side effects. For this purpose, magnetic generation 4 dendrimeric nanoparticles were
prepared to carry chemotherapeutic agent doxorubicin (G4-DOX) and immune modulator polyinosinic:polycytidylic acid [Poly(I:C)].
As previously reported, DOX and Poly(I:C) was loaded onto G4 nanoparticles (PIC-G4-DOX). Cellular internalization study using
confocal microscopy demonstrated high levels of cellular internalization of PIC-G4-DOX nanoparticles by MCF-7 cells. This resulted in
higher efficacy of PIC-G4-DOX nanoparticles in killing MCF-7 breast cancer cells. Alteration in the expression levels of selected genes
was determined by RT-qPCR analyses. Proapoptotic NOXA, PUMA, and BAX genes were upregulated, and SURVIVIN, APOLLON,
and BCL-2 genes were downregulated, indicating the cell-killing effectiveness of PIC-G4-DOX nanoparticles. Gene expression analysis
provided some insights into the possible molecular mechanisms on cytotoxicity of DOX and Poly(I:C) delivered through G4 magnetic
nanoparticles. The results demonstrated that PIC-G4-DOX can be useful for targeted delivery affecting apoptotic pathways, resulting
in an advanced degree of cancer-cell–killing. They are promising for targeting cancer-cells because of their stability, biocompatibility,
higher internalization, and toxicity.
Key words: Targeted drug delivery, magnetic dendrimeric nanoparticles, Poly(I:C), doxorubicin, gene expression

1. Introduction
Nanotechnology-based delivery vehicles, such as
nanoparticles, nanocapsules, micelles, or dendrimers,
have great potential to be utilized in nanomedicine
to deliver conventional drugs, recombinant proteins,
vaccines, and more recently genetic material, by
addressing the problems related to poor solubility, high
toxicity, nonspecific delivery, in vivo degradation, and
short circulation half-lives of conventional drugs, which
often limits optimal dosage at the target site (Bansal et al.,
2020).
Magnetic nanoparticles are popular for many
biological applications, including targeted drug delivery
and magnetic hyperthermia, in which they can be directed
to a tumor site under a magnetic field. Superparamagnetic
iron oxide nanoparticles, which align in the presence of
a magnetic field, are mostly preferred for the targeted
delivery of drugs and diagnostics agents. In order to obtain
biocompatible, multifunctional magnetic nanoparticles,

their surfaces can be modified with different organic and
inorganic polymers (Ling et al., 2019).
Dendrimers are hyperbranched globular polymeric
nanostructures with a unique tree-like architecture and
compact spherical geometry in solution. Dendrimers can
be prepared at various generations, which involves the
multiple layers of branched structures. They are utilized
in targeted drug delivery with their nano size, narrow
polydispersity index, controlled molecular structure,
and multiple functional group availability (Svenson and
Tomalia, 2012). Chemotherapeutic drugs or nucleic
acids such as siRNA, DNA/RNA vaccines, and targeting
moieties are conjugated to the terminal functional groups
of dendrimers which act as nonviral transfection agents
in gene therapy (Palmerston et al., 2017). Dendrimers
are suitable candidates for the delivery of nucleic acids
attributed to structural flexibility and hyperbranched
architectures (Pedziwiatr-Werbicka et al., 2013). While the
net charge of dendrimers is positive under physiological
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conditions, it is possible to form complexes with nucleic
acids. This complex can then bind to negatively charged
surface molecules on a cell membrane. Followed
by internalization of nanoparticles into the cells via
endocytosis, release of nucleic acids takes place (ParkerEsquivel et al., 2012).
Polyamidoamine
(PAMAM)
dendrimers
are
3-dimensional branched polymers used in gene delivery.
The highly branched structure maximizes surface area
and exposes surface functional groups for interactions,
making the dendrimers suitable for binding a variety
of molecules (Kaur et al., 2016). The positively charged
terminal amines of PAMAM dendrimers are thought to
bind to the negatively charged phosphate backbone groups
of the nucleic acid, facilitating an electrostatic interaction
between the dendrimers and nucleic acid. The higher
generation dendrimers are more positively charged than
the lower generations (Abedi-Gaballu et al., 2018).
Doxorubicin (DOX) is an anthracycline antibiotic
which inhibits DNA and RNA synthesis in mammalian
cells as an effective anticancer agent. It can efficiently
accumulate in the nucleus, intercalate with DNA, and
act as a cytostatic and apoptotic agent in cancer cells.
The production of free radicals and oxidative stress is
highly involved in the toxic and anticancer mechanisms
of DOX (Kim and Kim, 1972). The clinical application of
DOX has some limitations due to its serious side effects
(cardiotoxicity, heart damage) and the development of
resistance (Singal et al., 2000). DOX-loaded nanoparticles
has been used to overcome these limitations. DOX was
loaded into the cavities of synthesized dendrimer-coated
magnetic nanoparticles. Loading on PAMAM dendrimers
enhances the aqueous solubility and bioavailability of
DOX, and ensures its controlled release (Chanphai et al.,
2017). Moreover, nanoparticle-mediated delivery of DOX
copes with the drug resistance via bypassing Pgp-mediated
efflux pumps (Da Silva et al., 2017)
Poly (I:C) is a synthetic dsRNA which has been well
characterized. The structure of Poly (I:C) is similar to viral
dsRNA and boosts the immune response by activating
endosomal toll-like receptor 3 (TLR3) or cytosolic
melanoma differentiation-associated protein 5 (MDA5) and retinoic acid-inducible gene I (RIG-1) receptors.
It is a potent vaccine adjuvant and apoptotic agent
which stimulates TLR3 and activates interferons against
pathogens and cancer cells. Poly (I:C) improves the efficacy
of chemotherapeutic drugs when used concurrently in
clinical trials. However, Poly (I:C) cannot be taken up into
the cells by itself (Yoneyama et al., 2004)
Dendrimer was used to load DOX and attach Poly
(I:C) onto the magnetic nanoparticles (Khodadust et al.,
2014). PAMAM dendrimers form complexes with nucleic
acids, protect Poly (I:C) from nuclease degradation, and
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are considered cell-penetrating molecules. After the cell
penetration of the dendrimeric nanoparticles, Poly (I:C)
binds to the TLR3 receptors and activates apoptotic
pathways. The toxicity of the cationic dendrimers increases
with increasing generations; however, multiple studies
have demonstrated that generation 4 PAMAM dendrimers
(G4), such as the one used in this study, are nontoxic up to
250 µg/mL concentrations and effectively deliver nucleic
acids into the cells (Khodadust et al., 2013). In vitro
analyses have also proved that the higher generations
of cationic PAMAM dendrimers induce aggregation of
human platelets in plasma proportional to the number of
surface amines (Salvador et al., 2012)
Previously in our laboratory, different generations of
dendrimer-coated magnetic nanoparticles (DcMNPs)
were synthesized, characterized, and successfully used
for the delivery of DOX and codelivery of Poly (I:C) and
DOX (Khodadust et al., 2014). These formulations were
convenient for delivering anticancer agents into the breast
cancer cells, resulting in effective killing of cancer cells.
However, their effect on proapoptotic and antiapoptotic
signaling pathways involving changes in gene expression
levels is a matter for concern. Sustained change in the
expression of apoptotic family proteins (antiapototic Bcl2-like and proapototic subgroups) are very important in
the survival and development of different cancer types.
Therefore, the targeting of cellular antiapoptotic proteins
or application of proapoptotic proteins as therapeutic
modalities have emerged as key targets to be implemented
in cancer therapy (An et al., 2019). In this study,
quantitative PCR (qPCR) analyses were employed to
investigate the effects of drug-loaded/-unloaded G4 MNPs
on apoptotic and antiapoptotic gene expressions of MCF-7
cells. For this purpose, antiapoptotic BCL-2, SURVIVIN,
and APOLLON and proapoptotic BAX, NOXA, and
PUMA genes were chosen.
2. Materials and methods
2.1. Materials
Ferric chloride hexahydrate (FeCl36·H2O), ferrous chloride
tetrahydrate (FeCl24·H2O), ammonia solution (NH3)
(32%), 3-aminopropyl trimethoxysilane (APTS) [NH2
(CH2)3-Si-(OCH3)3], methylacrylate, methanol, ethanol
and ethylenediamine, phosphate buffer saline (PBS),
ethylenediaminetetraacetic acid, trisaminomethane,
1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide
hydrochloride (EDC), polyinosinic–polycytidylic acid
(Poly [I:C]), and acetic acid were purchased from Sigma
Aldrich (St. Louis, MO, USA) and were used in the synthesis
of PAMAM-coated MNPs. The 2,3-bis(2-methoxy-4nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2Htetrazoliumhydroxide (XTT) reagent was purchased from
Biological Industries (Kibbutz Beit-Haemek, Israel). DOX
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was kindly provided by Gulhane Military Academy (School
of Medicine, Ankara, Turkey). Human serum was donated
by the authors of this manuscript (Rouhollah Khodadust
and Pelin Mutlu) for physiological stability studies.
2.2. DOX loading and Poly (I:C) binding on G4 magnetic
dendrimeric nanoparticles
Poly (I:C)-bound DOX-loaded magnetic dendrimeric
nanoparticles (PIC-G4-DOX) were improved to obtain
an efficient drug delivery system as explained in our
previous studies (Khodadust et al., 2014). Briefly,
DOX was loaded on G4 with 96% drug entrapment.
Poly (I:C) was then bound covalently onto the surface
of G4-DOX nanoparticles through the 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride
(EDC) activation method (Sheehan et al., 1961). Poly (I:C)
loading on G4 was previously optimized, and the ratio of
Poly (I:C) to nanoparticles was reported as 1:10 (w/w) by
our group (Khodadust et al., 2014).
2.3. Cellular internalization of PIC-G4-DOX
MCF-7 cells were grown on cover glasses placed in 12-well
tissue culture plates in complete media. On the following
day, cells were incubated with G4-DOX solution for 3 h.
After the incubation, old medium was removed from the
plates and the cells were washed 3 times with PBS. DAPI
staining was performed according to the manufacturer’s
instructions. For this purpose, 300 µM DAPI intermediate
dilution was prepared by adding 2.1 µL of the 14.3 mM
DAPI stock solution to 100 µL PBS. Then 300-µM DAPI
intermediate solution diluted as 1:1000 in PBS was added
as needed to make a 300-nM DAPI stain solution. Next,
500 µL of the diluted DAPI staining solution was added
to the wells, incubated for 5 min, and washed 2–3 times
with PBS. The cells were visualized with a Zeiss confocal
laser scanning microscope (Zeiss LSM 700; Carl Zeiss
Microscopy GmbH, Oberkochen, Germany). The LSM
picture files were analyzed using Image J software.
2.4. Cytotoxicity of PIC-G4-DOX
Cytotoxicity of the free PIC, PIC-G4, and DOX solutions
at various concentrations was determined using the XTT
cell proliferation assay as described previously. According
to these results, the IC50 values of free PIC, PIC-G4, and
DOX were calculated as 450 µg/mL (PIC), 28 µg/mL (PIC),
and 170 µg/mL for free DOX, respectively (Khodadust et
al., 2014).
2.5. Expression of apoptosis-related genes
MCF-7 cells (300,000 cells per well) were seeded in a
6-well plate. After overnight incubation, cells were treated
with G4DcMNP, G4-DOX, PIC-G4-DOX, and free DOX.
According to the literature, about 18 h of treatment with
the required concentration of DOX could be enough to see
the drug’s toxicity effect at the mRNA level (Asnani et al.,
2018; Alessandrini el., 2018). Therefore, cells were treated

with 18µg/mL, 6µg/mL, and 0.6µg/mL of each nanoparticle
formulation for 18 h. After incubation, cells were collected
with Tri Pure RNA isolation reagent (Roche Diagnostics
GmbH, Mannheim, Germany) and stored at –80 °C until
used. RNA purity and quantity were determined using a
Nanodrop spectrometer (Thermo Scientific, Waltham,
MA, USA). Next, 1 mg RNA was treated with DNase I
(Thermo Scientific), which was then inactivated at 65
°C in the presence of EDTA. RNA was then converted
to cDNA using random hexamer and Revert Aid reverse
transcriptase (Thermo Scientific). Primers were designed
and verified with Primer3-web (http://primer3.ut.ee/) and
Primer blast (http://www.ncbi.nlm.nih.gov/tools/primerblast/) programs, respectively (Table).
All of the amplicons were amplified using SYBR Green
Master Mix (Roche) with reaction conditions as 95 °C
for 10 min enzyme activation, 40 cycles of 95 °C for 15
sec, and 60 °C for 1 min. RT-qPCR results were analyzed
with the 2–DDCt method (Livak and Schmittgen, 2001). Fold
changes are expressed relative to untreated MCF-7 cells.
3. Results and discussion
3.1. DOX loading and Poly (I:C) binding on G4
The surface of the G4-PAMAM dendrimer resembles
pockets. At neutral pH, an electrostatic repulsion happens
at the surface of the dendrimer owing to the positive
charge of the primary amines, which itself results in the
formation of a number of cavities (Martiniano et al., 2020).
Here, fourth-generation PAMAM dendrimers (G4) were
synthesized and loaded with DOX (Figure 1a–b). The drug
content, drug entrapment, and drug loading percentages
of G4 were identified as 13%, 96%, and 100%, respectively.
The equations for the calculations are given (Equations
1–3).
Equation 1:

𝑤𝑤
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 − 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
−
𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 +%, 𝑤𝑤
100
𝑤𝑤// =
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
− 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 ×
𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟
=
×
𝑜𝑜𝑜𝑜 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛
𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 +%,
=
× 100
100
+%, 𝑤𝑤
/
𝑤𝑤
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑤𝑤
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛
𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛
Equation 2: 𝑤𝑤 (𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 − 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚
𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
−
𝑜𝑜𝑜𝑜
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 +%, 𝑤𝑤
100
𝑤𝑤// =
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
− 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 ×
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
×
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒
𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 +%,
=
× 100
100
+%, 𝑤𝑤
/=
𝑤𝑤
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑤𝑤
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝑤𝑤
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 − 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
Equation
3
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
−
𝑜𝑜𝑜𝑜
𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙 +%, 𝑤𝑤
100
𝑤𝑤// =
(𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
− 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑜𝑜𝑜𝑜 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 ×
𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟
×
𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙 +%,
=
× 100
100
+%, 𝑤𝑤
/=
𝑤𝑤
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀
𝑤𝑤
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜
𝑜𝑜𝑜𝑜 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝

Poly (I:C) was covalently bound onto the surface of
G4-DOX in the presence of EDC reagent and imidazole
at pH 6.5 (Figure 1c). Since Poly (I:C) covers the surface
of dendrimers, binding Poly (I:C) in advance makes the
DOX unable to enter the cavities of the dendrimeric
nanoparticles. For this reason, DOX was loaded into the
cavities of G4 before Poly (I:C) binding. Loading DOX
into the cavities of nanoparticles in advance allows us to
overcome the steric hindrance at the dendrimer surface
and improves the stability and reactivity of NPs (Khandare
et al., 2005). The distance between the surface functional
groups increased with the increased amounts of DOX
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Table. Primer sequences of β-actin, SURVIVIN, APOLLON,
BCL-2, NOXA, PUMA and BAX genes.
Primer

Sequences

Β-actin sense

5’CCAACCGCGAGAAGATGA3’

Β-actin antisense

5’CCAGAGGCGTACAGGGATAG3’

SURVIVIN sense

5’AGCCAGATGACGACCCATAGAGG3’

SURVIVIN antisense

5’AAAGGAAAGCGCAACCGGACGA3’

APOLLON sense

5’TAGTGATATGCCTCGTTTGTTGG3’

APOLLON antisense

5’TTCTGTGTGTGCTCACCTTTC3’

BCL-2 sense

5’TGTGGCCTTCTTTGAGTTC3’

BCL-2 antisense

5’CGGTTCAGGTACTCAGTCATC3’

NOXA sense

5’TGATATCCAAACTCTTCTGC3’

NOXA antisense

5’ACCTTCACATTCCTCTCAA3’

PUMA sense

5’GACGACCTCAACGCACAGTA3’

PUMA antisense

5’GTAAGGGCAGGAGTCCCAT3’

BAX sense

5’TCTGACGGCAACTTCAACTG3’

BAX antisense

5’TTGAGGAGTCTCACCCAACC3’

loaded inside the cavities of G4. This improved the binding
efficiency of Poly (I:C). Accordingly, the surface functional
groups became 10 times more responsive to Poly (I:C)
binding when the DOX was loaded into the cavities of G4
(Khodadust et al., 2014). According to the DLS results,
after DOX loading and Poly (I:C) modification, the size
of DcMNPs increased from 60 ±15 nm to 100 ±25 nm.
Comparison of TEM results of DcMNPs and PIC-G4DOX demonstrated that doxorubicin loading together

with Poly (I:C) modification improves the dispersivity of
the complex (Figure 2).
3.2. Cellular internalization of G4-DOX
In order to specify the cellular internalization of DOX
loaded nanoparticles, breast cancer cells were incubated
with G4-DOX for 3 h. After cell fixation and nuclear
staining with DAPI, the images of the cells were obtained
by confocal laser scanning microscope with 2 different
objectives, allowing different regions of cells to be viewed.
Confocal laser scanning microscope images of G4-DOX
nanoparticle-treated cells with DAPI filter (Figures 3a and
3b) and red filter (suitable for DOX at 543 nm excitation
and 570 nm emission longpass filter) (Figures 3c and
3d), together with merged images, demonstrated that the
drug-loaded nanoparticles were internalized into all cells
(Figures 3e and 3f).
Free DOX can pass through the cell membrane by
diffusion, which is driven by a concentration gradient.
Due to its hydrophobic anthracycline backbone, cellular
membrane is highly permeable to DOX (Yacoub et
al., 2011). Therefore, free DOX passes through the cell
membrane; some of it enters the nucleus, where it inhibits
DNA replication (Sui et al., 2014).
Although free DOX passes easily through the cell
membrane, its hydrophobic structure is a disadvantage for
solubility in aqueous media. Another disadvantage of DOX
application is its harsh cardiotoxic side effects (Singal et al.,
2000). The development of drug resistance mechanisms
restricts free DOX application in cancer chemotherapy
(Mirski et al., 1987). On the other hand, DOX-loaded G4
(G4-DOX) is taken up into the cells by endocytosis, which
bypasses the drug resistance mechanisms. DOX is released

Figure 1. Schematic representation of magnetic generation 4 dendrimeric nanoparticles (G4) (a), chemotherapeutic agent doxorubicinloaded (the red layer) nanoparticles (G4-DOX) (b) and immune modulator polyinosinic:polycytidylic acid Poly(I:C) bound nanoparticles
(PIC-G4-DOX) (c).
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Figure 2. DLS results of G4DcMNPs (a) and PIC-G4-DOX (b). TEM images of G4DcMNPs (c) and PIC-G4-DOX (d). The scale bar in
the TEM images shows 100 nm.

from G4-DOX nanoparticles in a controlled manner inside
the acidic endosomes and is diffused into the cytosol before
it finally enters the cell nucleus (Khodadust et al., 2013).
3.3. Cytotoxicity of PIC-G4-DOX
Our group previously demonstrated that G4 and G7 do
not show any significant cytotoxicity in MCF-7 cells
at concentrations up to 250 µg/mL and 120 µg/mL,
respectively (Khodadust et al., 2014). Moreover, loading of
5 µg/mL Poly (I:C) on 80 µg/mL G7 nanoparticles results
in 30% cell death. However, the surface functional groups
of G7 can be efficiently bound with therapeutic agents such
as Poly (I:C); their rigid surface structures do not allow
other drugs to enter the cavities of nanoparticles. On the
other hand, the surface structures of G4 are more flexible
than G7, which allows drugs to enter the cavities. Thus,
the lower generations of dendrimers are more suitable for
drug loading and delivery with their lower toxicity. DOX
was loaded into the cavities of G4. This helps to overcome
steric hindrance at the surface and makes the surface
functional groups more appropriate for the binding of
therapeutic agents such as Poly (I:C) (Khodadust et al.,

2014). Poly (I:C) was then bound onto the surface of G4DOX through EDC activation. Its binding onto the surface
functional amine groups of dendrimers also improves the
biocompatibility of the nanoparticles by decreasing the
cationic load (Khandare et al., 2005).
Our previous results indicated that the codelivery of
DOX and Poly (I:C) on G4 are more effective in killing
cancer cells than the delivery of either agent alone
(Khodadust et al., 2014). Such additive or synergistic
effect is not that obvious with G7 due to the low amounts
of DOX loaded. Lower generations of dendrimer-coated
magnetic nanoparticles with their internal cavities and
longer circulation time in blood are more suitable for drug
delivery applications (Khodadust et al., 2014).
3.4. Expression of apoptosis-related genes
The apoptotic signaling pathway is regulated by a group of
complex molecules in a network, involving the expression
changes of distinct proapoptotic and antiapoptotic genes.
In cancer cells, apoptosis can be induced either by the
activation of upstream molecules of apoptosis pathway or
by the inhibition of antiapoptotic factors.
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Figure 3. Cellular uptake images of G4-DOX internalized with MCF-7 cells at 10x and 40x resolution. Visualization of DAPI nuclear
labeled G4-DOX treated cells with DAPI filter (a and b, 10x and 40x, respectively). Visualization of G4-DOX treated cells with red filter
(excitation 543 nm, emission longpass filter 570 nm) sutiable for doxorubicin (c and d, 10x and 40x, respectively). Merged images of
DOX (red) and nuclei (blue) in G4-DOX treated cells (e and f, 10x and 40x, respectively).

DOX increases the production of reactive oxygen
species (ROS) and stimulates protein degradation in the
cell with the caspase-3 and ubiquitin–proteasome pathway.
Application of free DOX, G4, G4-DOX, and PIC-G4-DOX
changed the expression levels of certain genes, including
SURVIVIN, APOLLON, and BCL-2 (antiapoptotic
proteins), as well as NOXA, PUMA, and BAX (major
regulators of the intrinsic apoptotic pathway) (Figure 4).
SURVIVIN, a member of the inhibitor of apoptosis
protein (IAP) family, is a caspase blocker that selectively
inhibits the intrinsic apoptosis pathway. SURVIVIN
expression is a determinant of DOX response in breast
cancer cells (Faversani et al., 2014). It has also been
reported that P-gp–mediated resistance to DOX is
modulated by SURVIVIN (Faversani et al., 2014). We
showed that SURVIVIN expression was upregulated 2-fold
at high doses of free DOX (18 µg/mL and 6 µg/mL), while
delivery of DOX in G4 with Poly (I:C) (PIC-G4-DOX) or
alone (G4-DOX) reduced the expression of SURVIVIN at
all 3 doses (18 µg/mL, 6 µg/mL, and 0.6 µg/mL) compared
to G4 (Figure 4a). Codelivery of DOX and Poly (I:C) in
G4 could prevent SURVIVIN induction, which may be the
potential mechanism for increased cytotoxicity compared
to free DOX. It has been demonstrated that Poly (I:C)
downregulates the expression of antiapoptotic proteins,
especially SURVIVIN and BCL-XL in HCC cells, which is
compatible with our findings (Yuan et al., 2008). However,
there are other reports that imply independence of DOX
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response from SURVIVIN status. According to De
Moraes’s (2013) study, SURVIVIN expression was reduced
by 80% after treatment with 5mM DOX in MCF-7 cells
for 24 h (De Moraes et al., 2013), which is contradictory
to our results. SURVIVIN overexpression does not cause
resistance to DOX in MCF-7 cells (Liu et al., 2007).
The silencing of the APOLLON gene, an inhibitor of
apoptosis protein (IAP), can lead to increased apoptosis
in various breast cancer cell lines by activating caspases
3, 8, and 9 (Yoneda et al., 2008). Unlike other IAPs such
as SURVIVIN, XIAP (De Moraes et al., 2013; Liu et al.,
2007), siRNA-mediated knockdown of APOLLON had
more pronounced cytotoxic effect on MCF-7 cells (Yoneda
et al., 2008). Knockdown of the APOLLON gene has also
been reported to enhance chemosensitivity to a cisplatin/
docetaxel regimen (Zhang et al., 2014). We observed that
both G4-DOX and G4-PIC-DOX caused dose-dependent
downregulation in APOLLON expression (Figure 4b),
while APOLLON expression in cells treated with free
DOX remained in around 30% of untreated cells in all
doses. This is the first report of DOX causing APOLLON
downregulation in breast cancer cells.
BCL-2 is one of the major antiapoptotic members of the
BCL-2 family involved in the intrinsic apoptotic pathway.
It has been shown that BCL-2 was downregulated in MCF7 cells in response to DOX (Chorna et al., 2005) and that
BCL-2 overexpression conferred resistance to DOX in
MCF-7 cells (Zhang et al., 2014). Here we observed that
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G4-DOX and PIC-G4-DOX downregulates BCL-2 slightly
more than free DOX at higher doses (6 and 18 mg/mL).
We did not see a significantly dose-dependent response
in BCL-2 expression after the application of free DOX
(Figure 4c). Previously it was shown that Poly I:C treatment
downregulates BCL-2 in dose-dependent manner in
human umbilical vein endothelial cells (HUVECs) (Sun et
al., 2011). However, we did not observe either an additive
or a synergistic effect between Poly I:C and DOX in BCL-2
levels on MCF-7 cells.
PUMA is a BH3-only proapoptotic protein that is
generally induced by p53. The BH3 (BCL-2 Homology
3) domain is referred to as the “death domain” and is the
minimum requirement for a protein to have proapoptotic
functions. Previous reports showed that the effect of DOX
treatment on PUMA expression was highly contextdependent, where in some cells PUMA expression
remained constant while in others it gradually increased
first and then decreased. In 6 h of DOX treatment, PUMA
expression increased in a dose-dependent manner in
MCF-7 cells (Dudgeon et al., 2012). Our results showed
that 6 and 18 mg/mL of free DOX downregulated
PUMA by 10-fold while the lowest dose displayed 2-fold
upregulation (Figure 4d). This could be explained by
the observation that PUMA expression may gradually
increase and then decrease upon various DOX treatments,
where an 18-h treatment might fall in the “decline” phase.
When DOX was delivered via nanoparticles as G4-DOX
and PIC-G4-DOX, PUMA expression was inversely
correlated with the dose. This was compatible with the
results obtained with treatment of free DOX. Therefore,
we hypothesized that since the bioavailability of DOX and
exposure to high-dose DOX are not as high as free DOX in
treatments with nanoparticles due to the gradual release,
the downregulation phase of PUMA expression would
have come later. Thus, PUMA expression levels might have
started to decline in 18 h compared to an equivalent dose
of free DOX, which might enable a longer period of high
PUMA expression in G4 nanoparticle-treated cells.
NOXA is another proapoptotic protein induced by
p53. NOXA is upregulated by DOX treatment in various
breast cancer and neuroblastoma cell lines (Dudgeon et
al., 2012). In addition, Poly I:C treatment upregulated
NOXA in a time-dependent manner in human umbilical
vein endothelial cells (HUVECs) (Davis et al., 2003). We
demonstrated that G4-DOX and PIC-G4-DOX upregulated
NOXA (10-fold to 20-fold), the 6 mg/mL dose being the
highest NOXA inducer in both cases. At the lowest dose,
neither formulation induced NOXA at a significant level
(Figure 4e). At the highest doses of free DOX, NOXA
expression remained approximately the same as untreated
MCF-7 cells, while it was 12-fold upregulated by the lowest
dose of DOX. Based on these observations, we could

suggest that NOXA could follow a similar expression
pattern to PUMA under DOX treatment. In addition, the
data suggested that there might be a contribution of Poly
I:C in NOXA expression. It was observed that in 18 h at
both 6 and 18 mg/mL, PIC-G4-DOX induced NOXA more
efficiently than G4-DOX at the corresponding doses. These
results validate that the DOX routes cells to apoptosis with
the aid of PUMA and NOXA gene expressions.
BAX is a proapoptotic BCL-2 family member of the
major intrinsic apoptotic pathway. It has been previously
shown that DOX induces BAX expression in MCF-7
cells (Davis et al., 2003). However, our results displayed
that free DOX downregulated BAX expression by half
in all 3 doses (Figure 4f). We observed approximately 3and 2-fold upregulation of BAX levels at 0.6 mg/mL G4DOX and PIC-G4-DOX treatments, respectively, relative
to G4. In addition, empty G4 nanoparticles reduced BAX
expression by half, reflecting their nontoxicity.
Vivek et el. (2014) investigated the possible apoptotic
signaling pathways of “smart” pH-responsive chitosan
nanoparticles for controlled release of oxaliplatin. The
transcription levels of antiapoptotic SURVIVIN, BCL-2,
BAX, and Bik proteins are important in the induction of
apoptosis. The potential apoptotic mechanisms between
oxaliplatin and oxaliplatin-loaded chitosan nanoparticletreated MCF-7 cells were investigated at the protein level
by Western blot analyses. Oxaliplatin-loaded chitosan
nanoparticles significantly upregulated the protein
levels of BAX, Bik, Cytochrome C, caspase-9 and -3,
and downregulated the antiapoptotic proteins such as
BCL-2 and SURVIVIN. The antiapoptotic protein BCL2 mainly inhibits the mitochondrial pathways, while
SURVIVIN directly blocks the processing and activation
of effectors caspase-3 and caspase-9, which commonly
act downstream of apoptosis signaling pathways (R Vivek
et al., 2013), which suggests that oxaliplatin loaded with
chitosan nanoparticles induced apoptosis of MCF-7 cells
through the intrinsic apoptotic signaling pathway (Raju
Vivek et al., 2014).
Chen et al. studied a novel DOX delivery system based
on titanium dioxide (TiO2) nanoparticles to enhance the
anticancer efficacy of a drug while reducing its side effects.
They explored the changes in the expression levels of
apoptosis-regulating proteins including BAX, BCL-2, and
caspase 3 by Western blot, and showed that DOX-loaded
TiO2 nanoparticles are more efficient in BAX induction
and BCL-2 repression compared to free DOX in a human
SMMC-7721 hepatocellular carcinoma cell line (Chen
et al., 2011). Upregulated BAX leads to the disruption of
mitochondrial membrane integrity, resulting in caspase-3
activation and apoptosis (Ghavami et al., 2009).
The possible roles of these apoptosis-related genes of
interest inside the cells after the internalization of DOX
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Figure 4. Expression analysis of different classes of apoptosis-related genes: SURVIVIN (a), APOLLON (b), BCL-2 (c), PUMA (d)
NOXA (e) and BAX (f). MCF-7 cells were treated with bare nanoparticles (G4), DOX-loaded G4 nanoparticles (G4-DOX) and Poly (I:C)
modified-DOX loaded G4 nanoparticles (G4-DOX-PIC) and free DOX at different doses (18 µg/mL, 6 µg/mL, 0.6 µg/mL doxorubicin
equivalent amounts of nanoparticles) for 18 h.

and Poly I:C carrier G4 nanoparticles are schematized in
Figure 5. Poly I:C behaves like an RNA virus and induces
the intrinsic apoptosis pathway. After receptor-mediated
endocytosis, the synthetic dsRNA in the cytoplasm is
sensed by a class of ubiquitous cytoplasmic RNA helicases,
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retinoic acid inducible gene-I (RIG-I) (Yoneyama et al.,
2004), and melanoma differentiation Ag-5 (MDA-5) (Kato
et al., 2006), which trigger an antiviral signaling cascade
via the adaptor protein mitochondrial antiviral signaling
(MAVS) (also called IFN-b stimulator 1 [IPS-1]), virus-
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Figure 5. Simplified schematic representation for the molecular pathway of Poly (I:C) bound DOX loaded DcMNPs
(PIC-G4-DOX) on MCF-7 cells.

induced signaling adapter (VISA), caspase activation, and
recruitment domain adaptor inducing IFN-b (Cardif)
(Kawai et al., 2005; Seth, Sun, Ea, and Chen, 2005) of the
intrinsic apoptotic pathway (Vince and Tschopp., 2010).
As depicted in Figure 5, activation of p53 from stress
stimuli leads to the activation of BAX by upregulating
PUMA and NOXA, and finally initiates the intrinsic
apoptosis pathway. After activation, proapoptotic BAX
leads to the depolarization of mitochondria and release
of cytochrome c into the cytosol. Cytochrome c makes a
complex with apoptosis protease activation factor (APAF1) to form an apoptosome, then binds to pro-caspase 9.
Activated caspase 9 cleaves the effector caspase 3, which
is responsible for executing apoptosis. Thus, BAX is
an important factor required for mitochondrial outer
membrane permeabilization (MOMP) and the subsequent
release of cytochrome c (Strasser et al., 2011). Effective
MOMP depends on so-called BH3-only proteins such as
NOXA and PUMA that sense the apoptotic stimulus.
MAVS-dependent signaling results in the activation
of the transcription factors Nuclear Factor kappa B (NF-

kB) and interferon regulatory factor (IRFs), such as IRF-3,
which can act separately to induce inflammatory cytokines
and chemokines or act together as part of an enhanceosome
to induce type I interferons (IFNs). Activation of RIG-I
and subsequent downstream MAVS signaling can induce
transcription of the proapoptotic BH3-only proteins
NOXA and PUMA independent of p53, resulting in
activation of the intrinsic apoptotic pathway, whereby
BAX functions to disrupt mitochondrial membrane
integrity leading to cytochrome C release, formation of
apoptosome, caspase 3 activation, and apoptosis (Figure
5) (Besch et al., 2009).
4. Conclusion
In conclusion, we have reported on the fourth generation
(G4) of magnetic dendrimeric nanoparticles as a drug
delivery system. Furthermore, applicability of these
nanoparticles as a carrier for the delivery of the cationic
anticancer drug DOX and Poly (I:C) was demonstrated
in vitro. Codelivery of DOX and Poly (I:C) on G4 were
more effective in killing cancer cells than the delivery of
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either agent alone. Enhanced cytotoxicity of a drug when
loaded on nanoparticles can be attributed to the higher
internalization of nanoparticles as compared to the free
drug. Although the same amounts of free DOX were applied,
higher efficacy is obtained with G4 since higher amounts
of nanoparticles enter the cells. This shows the important
role of G4 dendrimeric nanoparticles as an efficient carrier
for the delivery of anticancer drugs. Furthermore, death
mechanisms of MCF-7 breast cancer cells cultured with
DOX and Poly (I:C) carrier G4 nanoparticles have been
investigated with the RT-qPCR method. The expression

levels of certain proapoptotic (NOXA, PUMA, and BAX)
and antiapoptotic genes (SURVIVIN, APOLLON, BCL2) have changed in accordance with the amount of drugloaded nanoparticles. Synthesized nanoparticles have
exhibited superior cancer-cell–killing potential since they
are internalized at high amounts by the cells and alter the
pro- and antiapoptotic pathways. Development of magnetic
dendrimeric nanocarriers that can target tumors and
release of drugs at specific tumor sites represents a valuable
solution for overcoming drug resistance, minimization of
side effects, and effective antitumor therapy.
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